Zimmer Biomet Holdings, Inc. (ZBH)
USD 105.86
(-2.04%)
USD 105.86
(-2.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.27 Billion USD | -12.13% |
| 2022 | 3.72 Billion USD | -3.45% |
| 2021 | 3.86 Billion USD | -8.02% |
| 2020 | 4.19 Billion USD | -5.86% |
| 2019 | 4.45 Billion USD | -1.2% |
| 2018 | 4.51 Billion USD | 14.41% |
| 2017 | 3.94 Billion USD | 2.09% |
| 2016 | 3.86 Billion USD | 33.18% |
| 2015 | 2.9 Billion USD | 44.3% |
| 2014 | 2.01 Billion USD | -1.33% |
| 2013 | 2.03 Billion USD | 0.26% |
| 2012 | 2.03 Billion USD | -8.87% |
| 2011 | 2.23 Billion USD | 8.68% |
| 2010 | 2.05 Billion USD | 5.93% |
| 2009 | 1.93 Billion USD | -1.41% |
| 2008 | 1.96 Billion USD | 5.16% |
| 2007 | 1.86 Billion USD | 21.04% |
| 2006 | 1.54 Billion USD | 7.59% |
| 2005 | 1.43 Billion USD | 5.78% |
| 2004 | 1.35 Billion USD | 60.88% |
| 2003 | 843.3 Million USD | 34.56% |
| 2002 | 626.7 Million USD | 3.69% |
| 2001 | 604.4 Million USD | 25.47% |
| 2000 | 481.7 Million USD | 9.73% |
| 1999 | 439 Million USD | 14.03% |
| 1998 | 385 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 843.1 Million USD | 0.0% |
| 2024 Q3 | 969.5 Million USD | 19.33% |
| 2024 Q1 | 843.1 Million USD | -12.78% |
| 2023 Q4 | 966.6 Million USD | 3.18% |
| 2023 Q2 | 982.1 Million USD | 2.33% |
| 2023 Q1 | 959.7 Million USD | -1.87% |
| 2023 Q3 | 936.8 Million USD | -4.61% |
| 2023 FY | 3.27 Billion USD | -12.13% |
| 2022 FY | 3.72 Billion USD | -3.45% |
| 2022 Q2 | 935.4 Million USD | 1.82% |
| 2022 Q1 | 918.7 Million USD | -12.67% |
| 2022 Q3 | 896.2 Million USD | -4.19% |
| 2022 Q4 | 978 Million USD | 9.13% |
| 2021 Q2 | 1.16 Billion USD | 12.94% |
| 2021 Q3 | 1.07 Billion USD | -7.45% |
| 2021 Q1 | 1.03 Billion USD | -11.3% |
| 2021 Q4 | 1.05 Billion USD | -2.3% |
| 2021 FY | 3.86 Billion USD | -8.02% |
| 2020 Q3 | 1.03 Billion USD | 13.77% |
| 2020 Q1 | 1.09 Billion USD | -6.73% |
| 2020 Q2 | 910.1 Million USD | -16.6% |
| 2020 Q4 | 1.16 Billion USD | 12.18% |
| 2020 FY | 4.19 Billion USD | -5.86% |
| 2019 FY | 4.45 Billion USD | -1.2% |
| 2019 Q1 | 1.06 Billion USD | -17.25% |
| 2019 Q2 | 1.12 Billion USD | 5.73% |
| 2019 Q3 | 1.11 Billion USD | -0.91% |
| 2019 Q4 | 1.17 Billion USD | 5.23% |
| 2018 Q4 | 1.28 Billion USD | 20.62% |
| 2018 FY | 4.51 Billion USD | 14.41% |
| 2018 Q1 | 1.03 Billion USD | 1.43% |
| 2018 Q2 | 1.07 Billion USD | 4.44% |
| 2018 Q3 | 1.06 Billion USD | -1.32% |
| 2017 Q2 | 985.8 Million USD | -1.8% |
| 2017 FY | 3.94 Billion USD | 2.09% |
| 2017 Q4 | 1.01 Billion USD | 8.39% |
| 2017 Q3 | 938.4 Million USD | -4.81% |
| 2017 Q1 | 1 Billion USD | 1.08% |
| 2016 Q2 | 954.4 Million USD | 2.71% |
| 2016 Q3 | 987.6 Million USD | 3.48% |
| 2016 Q4 | 993.2 Million USD | 0.57% |
| 2016 FY | 3.86 Billion USD | 33.18% |
| 2016 Q1 | 929.2 Million USD | -31.1% |
| 2015 Q4 | 1.34 Billion USD | 50.16% |
| 2015 Q1 | 493.8 Million USD | -33.58% |
| 2015 Q3 | 898.2 Million USD | 69.63% |
| 2015 FY | 2.9 Billion USD | 44.3% |
| 2015 Q2 | 529.5 Million USD | 7.23% |
| 2014 Q4 | 743.5 Million USD | 51.86% |
| 2014 FY | 2.01 Billion USD | -1.33% |
| 2014 Q3 | 489.6 Million USD | -2.84% |
| 2014 Q2 | 503.9 Million USD | -1.54% |
| 2014 Q1 | 511.8 Million USD | -2.22% |
| 2013 Q2 | 512.9 Million USD | -0.27% |
| 2013 Q1 | 514.3 Million USD | -17.78% |
| 2013 Q4 | 523.4 Million USD | 7.39% |
| 2013 Q3 | 487.4 Million USD | -4.97% |
| 2013 FY | 2.03 Billion USD | 0.26% |
| 2012 FY | 2.03 Billion USD | -8.87% |
| 2012 Q3 | 483.5 Million USD | -5.29% |
| 2012 Q2 | 510.5 Million USD | -2.37% |
| 2012 Q1 | 522.9 Million USD | -17.61% |
| 2012 Q4 | 625.5 Million USD | 29.37% |
| 2011 Q1 | 513.9 Million USD | -0.79% |
| 2011 FY | 2.23 Billion USD | 8.68% |
| 2011 Q4 | 634.7 Million USD | 25.68% |
| 2011 Q3 | 505 Million USD | -12.46% |
| 2011 Q2 | 576.9 Million USD | 12.26% |
| 2010 Q3 | 469.2 Million USD | -17.32% |
| 2010 Q1 | 497.7 Million USD | -2.75% |
| 2010 Q2 | 567.5 Million USD | 14.02% |
| 2010 FY | 2.05 Billion USD | 5.93% |
| 2010 Q4 | 518 Million USD | 10.4% |
| 2009 Q1 | 475.5 Million USD | -5.71% |
| 2009 FY | 1.93 Billion USD | -1.41% |
| 2009 Q4 | 511.8 Million USD | 2.34% |
| 2009 Q3 | 500.1 Million USD | 11.11% |
| 2009 Q2 | 450.1 Million USD | -5.34% |
| 2008 Q1 | 465.6 Million USD | 3.01% |
| 2008 Q2 | 496.3 Million USD | 6.59% |
| 2008 Q4 | 504.3 Million USD | 1.04% |
| 2008 Q3 | 499.1 Million USD | 0.56% |
| 2008 FY | 1.96 Billion USD | 5.16% |
| 2007 Q2 | 427.8 Million USD | 3.36% |
| 2007 Q3 | 575.1 Million USD | 34.43% |
| 2007 FY | 1.86 Billion USD | 21.04% |
| 2007 Q1 | 413.9 Million USD | 5.8% |
| 2007 Q4 | 452 Million USD | -21.4% |
| 2006 Q4 | 391.2 Million USD | 3.74% |
| 2006 FY | 1.54 Billion USD | 7.59% |
| 2006 Q3 | 377.1 Million USD | -4.14% |
| 2006 Q1 | 382.3 Million USD | 6.31% |
| 2006 Q2 | 393.4 Million USD | 2.9% |
| 2005 FY | 1.43 Billion USD | 5.78% |
| 2005 Q1 | 363.7 Million USD | 2.16% |
| 2005 Q2 | 372.1 Million USD | 2.31% |
| 2005 Q3 | 339.7 Million USD | -8.71% |
| 2005 Q4 | 359.6 Million USD | 5.86% |
| 2004 Q1 | 337.6 Million USD | 4.07% |
| 2004 Q3 | 327.6 Million USD | -2.35% |
| 2004 Q2 | 335.5 Million USD | -0.62% |
| 2004 FY | 1.35 Billion USD | 60.88% |
| 2004 Q4 | 356 Million USD | 8.67% |
| 2003 Q2 | 178 Million USD | 3.97% |
| 2003 FY | 843.3 Million USD | 34.56% |
| 2003 Q3 | -100.06 Million USD | -156.21% |
| 2003 Q1 | 171.2 Million USD | 3.51% |
| 2003 Q4 | 324.4 Million USD | 424.21% |
| 2002 Q4 | 165.4 Million USD | 7.19% |
| 2002 FY | 626.7 Million USD | 3.69% |
| 2002 Q1 | 150 Million USD | -4.52% |
| 2002 Q2 | 157 Million USD | 4.67% |
| 2002 Q3 | 154.3 Million USD | -1.72% |
| 2001 Q3 | 157 Million USD | 9.71% |
| 2001 FY | 604.4 Million USD | 25.47% |
| 2001 Q2 | 143.1 Million USD | -3.51% |
| 2001 Q1 | 148.3 Million USD | 21.46% |
| 2001 Q4 | 157.1 Million USD | 0.06% |
| 2000 Q2 | 120.5 Million USD | -3.45% |
| 2000 Q1 | 124.79 Million USD | 0.0% |
| 2000 FY | 481.7 Million USD | 9.73% |
| 2000 Q4 | 122.1 Million USD | 6.54% |
| 2000 Q3 | 114.6 Million USD | -4.9% |
| 1999 FY | 439 Million USD | 14.03% |
| 1998 FY | 385 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 79.15% |
| Allurion Technologies Inc. | 120.57 Million USD | -2616.981% |
| Artivion, Inc. | 223.43 Million USD | -1366.205% |
| Avanos Medical, Inc. | 375.5 Million USD | -772.437% |
| Butterfly Network, Inc. | 162.46 Million USD | -1916.422% |
| Butterfly Network, Inc. | 162.46 Million USD | -1916.422% |
| Bio-Rad Laboratories, Inc. | 1.04 Billion USD | -212.73% |
| Boston Scientific Corporation | 7.47 Billion USD | 56.191% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -18699.495% |
| CONMED Corporation | 564.24 Million USD | -480.602% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | -5.989% |
| Paragon 28, Inc. | 210.1 Million USD | -1459.257% |
| Glaukos Corporation | 367.83 Million USD | -790.614% |
| Globus Medical, Inc. | 887.16 Million USD | -269.268% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -476.259% |
| Integer Holdings Corporation | 250.95 Million USD | -1205.393% |
| Medtronic plc | 16.12 Billion USD | 79.689% |
| Nevro Corp. | 389.36 Million USD | -741.363% |
| Owlet, Inc. | 51.21 Million USD | -6296.064% |
| Penumbra, Inc. | 590.87 Million USD | -454.43% |
| Vicarious Surgical Inc. | 80.66 Million USD | -3961.191% |
| Smith & Nephew plc | 3.46 Billion USD | 5.509% |
| Sonendo, Inc. | 68.46 Million USD | -4684.927% |
| STERIS plc | 1.4 Billion USD | -133.94% |
| Stryker Corporation | 9.2 Billion USD | 64.426% |
| Vapotherm, Inc. | 66.02 Million USD | -4861.757% |